Literature DB >> 6205589

Genital warts and cervical cancer. IV. A colposcopic index for differentiating subclinical papillomaviral infection from cervical intraepithelial neoplasia.

R Reid, C R Stanhope, B R Herschman, C P Crum, S J Agronow.   

Abstract

Five colposcopic signs (thickness, color, contour, vascular atypia, and iodine staining) were graded into three objective categories representing (1) subclinical papillomaviral infection, (2) lower-grade dysplasia, and (3) grade 3 cervical intraepithelial neoplasia. Seventy-two colposcopically different biopsy specimens (25 of subclinical papillomaviral infection and 18 of grade 1, 18 of grade 2, and 11 of grade 3 cervical intraepithelial neoplasia) were collected from 52 women and interpreted by validated, quantitative histologic analysis. Attempts to grade lesions by the prominence of the acetowhitening reaction or the mere presence of aberrant surface capillaries were unsuccessful. In contrast, each of five new colposcopic criteria were significantly correlated with histologic severity. Differences in color, vascular atypia, and iodine staining were more predictive than those of thickness and contour. Combined into a weighted index, these colposcopic features were 96% correct in forecasting approximate histologic findings. Because this method relies upon critical analysis rather than pattern recall, the use of this colposcopic index greatly simplifies the learning of colposcopy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6205589     DOI: 10.1016/0002-9378(84)90597-0

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  13 in total

1.  Genital human papillomavirus infections and cancer: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

2.  Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men.

Authors:  Timothy Wilkin; Jeannette Y Lee; Shelly Y Lensing; Elizabeth A Stier; Stephen E Goldstone; J Michael Berry; Naomi Jay; David Aboulafia; David L Cohn; Mark H Einstein; Alfred Saah; Ronald T Mitsuyasu; Joel M Palefsky
Journal:  J Infect Dis       Date:  2010-10-15       Impact factor: 5.226

3.  AgNOR Count and its Correlation with Colposcopy in Suspicious Cervix.

Authors:  Ritu Goyal; Kaur Manjit Mohi; Manjit Bal Singh
Journal:  J Obstet Gynaecol India       Date:  2012-11-06

Review 4.  Pathogenesis of genital HPV infection.

Authors:  A Schneider
Journal:  Genitourin Med       Date:  1993-06

5.  Impact of sexual habits on the clinical evaluation of male HPV infection.

Authors:  A Rotola; S Costa; P Monini; C Vendra; G Guida; P Terzano; D Di Luca; G Martinelli; E Cassai
Journal:  Eur J Epidemiol       Date:  1994-08       Impact factor: 8.082

6.  Histological and cytological evidence of viral infection and human papillomavirus type 16 DNA sequences in cervical intraepithelial neoplasia and normal tissue in the west of Scotland: evaluation of treatment policy.

Authors:  J B Murdoch; L J Cassidy; K Fletcher; J W Cordiner; J C Macnab
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-06

7.  Production of interferons and change of the lymphocyte subpopulation phenotype in peripheral blood at cervical papillomavirus infection.

Authors:  L Lazarenko; M Spivak; V Lakatosh; L Kryvokhatska; O Mikhailenko; A Rudenko; L Tkáciková; I Mikula
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

8.  Interrelation of lymphocyte subpopulations in peripheral blood under cervical papillomavirus infection.

Authors:  V P Lakatosh; L M Lazarenko; L M Lyanenko; M V Azarskova; O M Mikhailenko; L Tkáciková; A M Boroda
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.629

9.  A critical evaluation of the use of the Schiller test in selecting blocks from the uterine cervix in suspected intraepithelial neoplasia.

Authors:  M K Heatley
Journal:  Ulster Med J       Date:  1995-10

10.  Development of biomarker panel to predict, prevent and create treatments tailored to the persons with human papillomavirus-induced cervical precancerous lesions.

Authors:  Liudmyla M Lazarenko; Olena E Nikitina; Evgen V Nikitin; Olga M Demchenko; Galyna V Kovtonyuk; Larysa O Ganova; Rostyslav V Bubnov; Veronika O Shevchuk; Natalia M Nastradina; Viktoria V Bila; Mykola Ya Spivak
Journal:  EPMA J       Date:  2014-01-06       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.